Lunai Bioworks
(NASDAQ) ENOB
Lunai Bioworks Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$125.52M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ENOB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lunai Bioworks
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
David Weinstein
Website
www.renovarogroup.comHeadquarters
Los Angeles, CA 90067-2012, US
ENOB Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
-706%
Net Income Margin
-651%
Return on Equity
-12%
Return on Capital
10%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$188.97M
EBITDA
$177.15M
Operating Cash Flow
$7.87M
Capital Expenditure
$0.00
Free Cash Flow
$7.87M
Cash & ST Invst.
$92.70K
Total Debt
$10.17M
Lunai Bioworks Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
22
N/A
Net Income
$1.80M
+75.2%
EBITDA
$1.81M
+59.9%
Quarterly Fundamentals
Net Cash
$2.26M
+62.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$213.66K
-68.3%
Short Term Debt
$2.54M
-55.4%
Return on Assets
-18.83%
N/A
Return on Invested Capital
10.21%
N/A
Free Cash Flow
$1.07M
+58.1%
Operating Cash Flow
$1.07M
+58.2%